Teva Presents Positive Safety and Efficacy Data for QNASL®; Avanir Announces Preliminary Feedback from the FDA on AVP-825 Print E-mail
By David Fowler   
Friday, 07 November 2014 18:54
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 7, 2014.
Read more...
 
Auspex Receives FDA Orphan Drug Designation Of SD-809; Actinium Pharmaceuticals Actimab-A Phase I/II Trial Interim Data Print E-mail
By William Kent   
Thursday, 06 November 2014 20:13
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 6, 2014.
Read more...
 
Alnylam Completes Phase 2 Enrollment; FDA Grants Orphan Drug Designation to Merrimack's MM-141 Print E-mail
By William Kent   
Wednesday, 05 November 2014 20:28
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 5, 2014.
Read more...
 
AstraZeneca And Pharmacyclics Enter Clinical Trial Collaboration To Evaluate IMBRUVICA®; Covidien's HawkOne Directional Atherectomy System Receives FDA 510(K) Clearance Print E-mail
By Josh Gee   
Tuesday, 04 November 2014 20:32
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 4, 2014.
Read more...
 
CEL-SCI Enrolls 22 Patients In Phase III Cancer Trial; Geron Announces Removal of Full Clinical Hold on Imetelstat IND Print E-mail
By David Fowler   
Monday, 03 November 2014 19:53
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 3, 2014.
Read more...
 
Biogen and Sobi Announce European Medicines Agency Validates ELOCTA™; BioLineRx Reports Results from Previous Phase 1/2 Trial for BCM (BL-1040) Print E-mail
By William Kent   
Friday, 31 October 2014 19:06
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 31, 2014.
Read more...
 
Immunomedics Provides Update On Phase 2 Study Of Isactuzumab Govitecan; Hemispherx Reports New Evidence of Ampligen(R) Print E-mail
By William Kent   
Thursday, 30 October 2014 19:00
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 30, 2014.
Read more...
 
Cara Therapeutics Announces Positive Results Of Peripheral Opioid; POZEN Appoints Senior VP and Chief Business Officer Print E-mail
By William Kent   
Wednesday, 29 October 2014 19:32
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 29, 2014.
Read more...
 
Chembio Falling After Failing To Provide Timeline On Product Deployment; Ambit Announces Expiration of Hart-Scott-Rodino Waiting Period Print E-mail
By Josh Gee   
Tuesday, 28 October 2014 21:28
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 28, 2014.
Read more...
 
Novavax To Launch Clinical Trial Of Ebola Vaccine; Sarepta Announces Update on Eteplirsen Print E-mail
By Marilyn Mullen   
Monday, 27 October 2014 15:55
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 27, 2014.
Read more...
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Page 20 of 369

Newsletter